214 related articles for article (PubMed ID: 31527799)
21. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8.
Wu X; Yen L; Irwin L; Sweeney C; Carraway KL
Mol Cell Biol; 2004 Sep; 24(17):7748-57. PubMed ID: 15314180
[TBL] [Abstract][Full Text] [Related]
22. The UBC Domain Is Required for BRUCE to Promote BRIT1/MCPH1 Function in DSB Signaling and Repair Post Formation of BRUCE-USP8-BRIT1 Complex.
Ge C; Che L; Du C
PLoS One; 2015; 10(12):e0144957. PubMed ID: 26683461
[TBL] [Abstract][Full Text] [Related]
23. Usp8 promotes tumor cell migration through activating the JNK pathway.
Zhao Y; Peng D; Liu Y; Zhang Q; Liu B; Deng Y; Ding W; Zhou Z; Liu Q
Cell Death Dis; 2022 Mar; 13(3):286. PubMed ID: 35361778
[TBL] [Abstract][Full Text] [Related]
24. Regulation of endocytic sorting by ESCRT-DUB-mediated deubiquitination.
Wright MH; Berlin I; Nash PD
Cell Biochem Biophys; 2011 Jun; 60(1-2):39-46. PubMed ID: 21448666
[TBL] [Abstract][Full Text] [Related]
25. USP8 controls the trafficking and sorting of lysosomal enzymes.
MacDonald E; Urbé S; Clague MJ
Traffic; 2014 Aug; 15(8):879-88. PubMed ID: 24894536
[TBL] [Abstract][Full Text] [Related]
26. Identification of chemicals breaking the USP8 interaction with its endocytic substrate CHMP1B.
Journet A; Barette C; Aubry L; Soleilhac E; Fauvarque MO
SLAS Discov; 2022 Oct; 27(7):395-404. PubMed ID: 35995394
[TBL] [Abstract][Full Text] [Related]
27. The oncogenic role of ubiquitin specific peptidase (USP8) and its signaling pathways targeting for cancer therapeutics.
Islam MT; Chen F; Chen H
Arch Biochem Biophys; 2021 Apr; 701():108811. PubMed ID: 33600786
[TBL] [Abstract][Full Text] [Related]
28. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
[TBL] [Abstract][Full Text] [Related]
29. The Usp8 deubiquitination enzyme is post-translationally modified by tyrosine and serine phosphorylation.
Meijer IM; Kerperien J; Sotoca AM; van Zoelen EJ; van Leeuwen JE
Cell Signal; 2013 Apr; 25(4):919-30. PubMed ID: 23333852
[TBL] [Abstract][Full Text] [Related]
30. The expression of ubiquitin-specific peptidase 8 and its prognostic role in patients with breast cancer.
Qiu H; Kong J; Cheng Y; Li G
J Cell Biochem; 2018 Dec; 119(12):10051-10058. PubMed ID: 30132974
[TBL] [Abstract][Full Text] [Related]
31. USP8: a novel therapeutic target for Cushing's disease.
Jian F; Cao Y; Bian L; Sun Q
Endocrine; 2015 Nov; 50(2):292-6. PubMed ID: 26162929
[TBL] [Abstract][Full Text] [Related]
32. Regulation of ubiquitin-specific processing protease 8 suppresses neuroinflammation.
Zhu L; Bi W; Lu D; Zhang C; Shu X; Wang H; Qi R; Shi Q; Lu D
Mol Cell Neurosci; 2015 Jan; 64():74-83. PubMed ID: 24861766
[TBL] [Abstract][Full Text] [Related]
33. Clec16a, Nrdp1, and USP8 Form a Ubiquitin-Dependent Tripartite Complex That Regulates β-Cell Mitophagy.
Pearson G; Chai B; Vozheiko T; Liu X; Kandarpa M; Piper RC; Soleimanpour SA
Diabetes; 2018 Feb; 67(2):265-277. PubMed ID: 29180353
[TBL] [Abstract][Full Text] [Related]
34. BRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1.
Ge C; Che L; Ren J; Pandita RK; Lu J; Li K; Pandita TK; Du C
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1210-9. PubMed ID: 25733871
[TBL] [Abstract][Full Text] [Related]
35. CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis.
Crespo-Yàñez X; Aguilar-Gurrieri C; Jacomin AC; Journet A; Mortier M; Taillebourg E; Soleilhac E; Weissenhorn W; Fauvarque MO
PLoS Genet; 2018 Jun; 14(6):e1007456. PubMed ID: 29933386
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-specific protease 8 deubiquitinates Sec31A and decreases large COPII carriers and collagen IV secretion.
Kawaguchi K; Endo A; Fukushima T; Madoka Y; Tanaka T; Komada M
Biochem Biophys Res Commun; 2018 May; 499(3):635-641. PubMed ID: 29604273
[TBL] [Abstract][Full Text] [Related]
37. Recurrent gain-of-function USP8 mutations in Cushing's disease.
Ma ZY; Song ZJ; Chen JH; Wang YF; Li SQ; Zhou LF; Mao Y; Li YM; Hu RG; Zhang ZY; Ye HY; Shen M; Shou XF; Li ZQ; Peng H; Wang QZ; Zhou DZ; Qin XL; Ji J; Zheng J; Chen H; Wang Y; Geng DY; Tang WJ; Fu CW; Shi ZF; Zhang YC; Ye Z; He WQ; Zhang QL; Tang QS; Xie R; Shen JW; Wen ZJ; Zhou J; Wang T; Huang S; Qiu HJ; Qiao ND; Zhang Y; Pan L; Bao WM; Liu YC; Huang CX; Shi YY; Zhao Y
Cell Res; 2015 Mar; 25(3):306-17. PubMed ID: 25675982
[TBL] [Abstract][Full Text] [Related]
38.
Joshi K; Mazumdar V; Nandi BR; Radhakrishnan GK
Infect Immun; 2024 Feb; 92(2):e0028923. PubMed ID: 38174929
[No Abstract] [Full Text] [Related]
39. Effect of deubiquitinase USP8 on hypoxia/reoxygenation‑induced inflammation by deubiquitination of TAK1 in renal tubular epithelial cells.
Zhang Y; Luo Y; Wang Y; Liu H; Yang Y; Wang Q
Int J Mol Med; 2018 Dec; 42(6):3467-3476. PubMed ID: 30221684
[TBL] [Abstract][Full Text] [Related]
40. NFκB2 p52 stabilizes rhogdiβ mRNA by inhibiting AUF1 protein degradation via a miR-145/Sp1/USP8-dependent axis.
Xu J; Hua X; Jin H; Zhu J; Li Y; Li J; Huang C
Mol Carcinog; 2019 May; 58(5):777-793. PubMed ID: 30604907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
